HEXAOM (ALHEX.PA) Fundamental Analysis & Valuation

EPA:ALHEX • FR0004159473

Current stock price

30.2 EUR
-0.3 (-0.98%)
Last:

This ALHEX.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ALHEX.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALHEX was profitable.
  • ALHEX had a negative operating cash flow in the past year.
  • Of the past 5 years ALHEX 4 years were profitable.
  • Each year in the past 5 years ALHEX had a positive operating cash flow.
ALHEX.PA Yearly Net Income VS EBIT VS OCF VS FCFALHEX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

  • ALHEX has a Return On Assets (1.46%) which is comparable to the rest of the industry.
  • ALHEX has a Return On Equity (3.94%) which is comparable to the rest of the industry.
  • With a Return On Invested Capital value of 3.70%, ALHEX perfoms like the industry average, outperforming 51.52% of the companies in the same industry.
  • ALHEX had an Average Return On Invested Capital over the past 3 years of 8.77%. This is in line with the industry average of 9.69%.
  • The 3 year average ROIC (8.77%) for ALHEX is well above the current ROIC(3.70%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 1.46%
ROE 3.94%
ROIC 3.7%
ROA(3y)1.03%
ROA(5y)1.76%
ROE(3y)1.4%
ROE(5y)4.65%
ROIC(3y)8.77%
ROIC(5y)8.58%
ALHEX.PA Yearly ROA, ROE, ROICALHEX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

  • ALHEX has a Profit Margin of 1.46%. This is comparable to the rest of the industry: ALHEX outperforms 48.48% of its industry peers.
  • ALHEX's Profit Margin has declined in the last couple of years.
  • ALHEX has a Operating Margin (2.30%) which is comparable to the rest of the industry.
  • ALHEX's Operating Margin has declined in the last couple of years.
  • ALHEX has a worse Gross Margin (21.14%) than 78.79% of its industry peers.
  • ALHEX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.3%
PM (TTM) 1.46%
GM 21.14%
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y-3.63%
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5YN/A
ALHEX.PA Yearly Profit, Operating, Gross MarginsALHEX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ALHEX.PA Health Analysis

2.1 Basic Checks

  • ALHEX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • ALHEX has about the same amout of shares outstanding than it did 1 year ago.
  • The debt/assets ratio for ALHEX has been reduced compared to a year ago.
ALHEX.PA Yearly Shares OutstandingALHEX.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M
ALHEX.PA Yearly Total Debt VS Total AssetsALHEX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • ALHEX has an Altman-Z score of 2.09. This is not the best score and indicates that ALHEX is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of ALHEX (2.09) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.40 indicates that ALHEX is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.40, ALHEX is in line with its industry, outperforming 57.58% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 2.09
ROIC/WACC0.53
WACC7%
ALHEX.PA Yearly LT Debt VS Equity VS FCFALHEX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

  • A Current Ratio of 1.31 indicates that ALHEX should not have too much problems paying its short term obligations.
  • ALHEX has a Current ratio (1.31) which is in line with its industry peers.
  • ALHEX has a Quick Ratio of 1.31. This is a bad value and indicates that ALHEX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of ALHEX (0.99) is better than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 0.99
ALHEX.PA Yearly Current Assets VS Current LiabilitesALHEX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ALHEX.PA Growth Analysis

3.1 Past

  • ALHEX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -68.84%.
  • The earnings per share for ALHEX have been decreasing by -13.22% on average. This is quite bad
  • The Revenue for ALHEX has decreased by -30.53% in the past year. This is quite bad
  • Measured over the past years, ALHEX shows a decrease in Revenue. The Revenue has been decreasing by -9.93% on average per year.
EPS 1Y (TTM)-68.84%
EPS 3Y-13.22%
EPS 5YN/A
EPS Q2Q%-48.59%
Revenue 1Y (TTM)-30.53%
Revenue growth 3Y-9.93%
Revenue growth 5YN/A
Sales Q2Q%-26.54%

3.2 Future

  • The Earnings Per Share is expected to grow by 37.93% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, ALHEX will show a small growth in Revenue. The Revenue will grow by 3.02% on average per year.
EPS Next Y2.44%
EPS Next 2Y37.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.32%
Revenue Next 2Y2.8%
Revenue Next 3YN/A
Revenue Next 5Y3.02%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALHEX.PA Yearly Revenue VS EstimatesALHEX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
ALHEX.PA Yearly EPS VS EstimatesALHEX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

4

4. ALHEX.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 23.05, which indicates a rather expensive current valuation of ALHEX.
  • The rest of the industry has a similar Price/Earnings ratio as ALHEX.
  • Compared to an average S&P500 Price/Earnings ratio of 25.79, ALHEX is valued at the same level.
  • With a Price/Forward Earnings ratio of 7.52, the valuation of ALHEX can be described as very cheap.
  • ALHEX's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ALHEX is cheaper than 66.67% of the companies in the same industry.
  • ALHEX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.80.
Industry RankSector Rank
PE 23.05
Fwd PE 7.52
ALHEX.PA Price Earnings VS Forward Price EarningsALHEX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALHEX indicates a somewhat cheap valuation: ALHEX is cheaper than 63.64% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.49
ALHEX.PA Per share dataALHEX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALHEX does not grow enough to justify the current Price/Earnings ratio.
  • ALHEX's earnings are expected to grow with 37.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)9.45
PEG (5Y)N/A
EPS Next 2Y37.93%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. ALHEX.PA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.54%, ALHEX has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 2.60, ALHEX has a dividend in line with its industry peers.
  • ALHEX's Dividend Yield is comparable with the S&P500 average which is at 1.91.
Industry RankSector Rank
Dividend Yield 1.54%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALHEX.PA Yearly Dividends per shareALHEX.PA Yearly Dividends per shareYearly Dividends per share 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

DP0%
EPS Next 2Y37.93%
EPS Next 3YN/A
ALHEX.PA Yearly Income VS Free CF VS DividendALHEX.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 20M -20M

More info and screens

Find the best dividend stocksShow peers with best dividend

ALHEX.PA Fundamentals: All Metrics, Ratios and Statistics

HEXAOM

EPA:ALHEX (3/18/2026, 7:00:00 PM)

30.2

-0.3 (-0.98%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)02-10
Earnings (Next)N/A
Inst Owners15.78%
Inst Owner ChangeN/A
Ins Owners2.84%
Ins Owner ChangeN/A
Market Cap209.59M
Revenue(TTM)617.81M
Net Income(TTM)9.04M
Analysts86.67
Price Target46.41 (53.68%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.54%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)16.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 23.05
Fwd PE 7.52
P/S 0.34
P/FCF N/A
P/OCF N/A
P/B 0.91
P/tB 2.07
EV/EBITDA 5.49
EPS(TTM)1.31
EY4.34%
EPS(NY)4.02
Fwd EY13.3%
FCF(TTM)-1.52
FCFYN/A
OCF(TTM)-0.85
OCFYN/A
SpS89.02
BVpS33.03
TBVpS14.6
PEG (NY)9.45
PEG (5Y)N/A
Graham Number31.2
Profitability
Industry RankSector Rank
ROA 1.46%
ROE 3.94%
ROCE 4.7%
ROIC 3.7%
ROICexc 6.23%
ROICexgc 17.99%
OM 2.3%
PM (TTM) 1.46%
GM 21.14%
FCFM N/A
ROA(3y)1.03%
ROA(5y)1.76%
ROE(3y)1.4%
ROE(5y)4.65%
ROIC(3y)8.77%
ROIC(5y)8.58%
ROICexc(3y)19.44%
ROICexc(5y)18.53%
ROICexgc(3y)71.44%
ROICexgc(5y)100.96%
ROCE(3y)11.34%
ROCE(5y)10.99%
ROICexgc growth 3Y-17.24%
ROICexgc growth 5YN/A
ROICexc growth 3Y-9.08%
ROICexc growth 5YN/A
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y-3.63%
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5YN/A
F-Score4
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA 2.97
Cap/Depr 27.37%
Cap/Sales 0.75%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.31
Quick Ratio 0.99
Altman-Z 2.09
F-Score4
WACC7%
ROIC/WACC0.53
Cap/Depr(3y)33.88%
Cap/Depr(5y)34.44%
Cap/Sales(3y)0.94%
Cap/Sales(5y)0.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.84%
EPS 3Y-13.22%
EPS 5YN/A
EPS Q2Q%-48.59%
EPS Next Y2.44%
EPS Next 2Y37.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.53%
Revenue growth 3Y-9.93%
Revenue growth 5YN/A
Sales Q2Q%-26.54%
Revenue Next Year-11.32%
Revenue Next 2Y2.8%
Revenue Next 3YN/A
Revenue Next 5Y3.02%
EBIT growth 1Y-50.48%
EBIT growth 3Y-15.33%
EBIT growth 5YN/A
EBIT Next Year75%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-136.13%
FCF growth 3Y-29.75%
FCF growth 5YN/A
OCF growth 1Y-114.31%
OCF growth 3Y-21.91%
OCF growth 5YN/A

HEXAOM / ALHEX.PA Fundamental Analysis FAQ

What is the fundamental rating for ALHEX stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALHEX.PA.


What is the valuation status for ALHEX stock?

ChartMill assigns a valuation rating of 4 / 10 to HEXAOM (ALHEX.PA). This can be considered as Fairly Valued.


How profitable is HEXAOM (ALHEX.PA) stock?

HEXAOM (ALHEX.PA) has a profitability rating of 4 / 10.


What are the PE and PB ratios of HEXAOM (ALHEX.PA) stock?

The Price/Earnings (PE) ratio for HEXAOM (ALHEX.PA) is 23.05 and the Price/Book (PB) ratio is 0.91.


Can you provide the financial health for ALHEX stock?

The financial health rating of HEXAOM (ALHEX.PA) is 3 / 10.